Form 4 holding
Former Director
Oncocyte Corp
- Security class
- Common Stock, no par value
- Shares / value
- 715,000
- Estimated value
- $153,654
- Report date
- 30 Jun 2023
- Price
- $0.2149
- Ownership
- Direct
John Peter Gutfreund - Former Director at Insight Molecular Diagnostics Inc.
Issuer-level insider activity
- Role
- Former Director
- Issuer ticker
- IMDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by John Peter Gutfreund since 28 Sep 2025
Reported holdings for John Peter Gutfreund in Insight Molecular Diagnostics Inc.
Form 4 holding
Former Director
Oncocyte Corp
- Security class
- Warrants to Purchase Common Stock
- Shares / value
- 45,000
- Estimated value
- Report date
- 30 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
Form 4 holding
Former Director
Oncocyte Corp
- Security class
- Common Stock, no par value
- Shares / value
- 0
- Estimated value
- Report date
- 30 Jun 2023
- Price
- $0.2149
- Ownership
- Indirect
Form 4 holding
Former Director
Oncocyte Corp
- Security class
- Warrants to Purchase Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 30 Jun 2023
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John Peter Gutfreund in Insight Molecular Diagnostics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.